SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Neuroscience
An SI Board Since June 2000
Posts SubjectMarks Bans
278 22 0
Emcee:  scott_jiminez Type:  Unmoderated
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
78Ron: I haven't looked at the portfolios, and I'm not going to. Howeverscaram(o)uche-9/29/2000
77Portfolios [OT] Three completely fictitious $100,000 portfolios have been creatscott_jiminez-9/28/2000
76<i>I try to stay neutral on these things. I don't know much about the nigel bates-9/28/2000
75tommysdad, >> TLRK has NO GPCR program of which I am aware.<< Me, tuck-9/28/2000
74>RE: Rick investigation about Ron's fraud on SI? Yes, I can confJohn Metcalf-9/28/2000
73tommysdad - there's quite a bit of evidence that estrogen has highly localizscott_jiminez-9/28/2000
72<<Lotsa companies working with GPCRs. Fewer with orphan receptors, perhapstommysdad-9/28/2000
71RE: Testimony! Did I miss single and simple word of sorry or apologize to SI coMiljenko Zuanic-9/27/2000
70Earlier today I made the statement, 'One could only hope that other neurologscott_jiminez-9/27/2000
69<b> To the Silicon Investor Community </b> Below please find a lettscott_jiminez-9/27/2000
68>> your cronies << Line up, guys and gals, and count off. Therescaram(o)uche-9/27/2000
67OK Richard. Since you're so desperate for this, I'll satisfy your your iscott_jiminez-9/27/2000
66Ron: Lots of thoughts....... 1. You brag about your neuro background, but....scaram(o)uche-9/27/2000
65Yesyerday's announcement by Biogen of the promising Avonex findings in largescott_jiminez-9/27/2000
64You sound to me (with all my non-neuroscience training capability) bit upset? WhMiljenko Zuanic-9/27/2000
63Jim - there's no better approach. All three of us have strengths and weaknesscott_jiminez-9/26/2000
62Scott, most of us investors, I believe, are not competent to judge scientific diJim Haynes-9/26/2000
61Hi, Scott. When will there be a good entry point for KLIC? Do you think that iaurileano-9/26/2000
60<<Two 600 pts pivotal placebo and active drug controlled completed. Highlyscott_jiminez-9/26/2000
59<<While win/win may be the case, there remain few patients treated thus faMiljenko Zuanic-9/25/2000
58Point taken; but plus 15% represents qualified excitement, surely. (Setting to onigel bates-9/25/2000
57Titan is reporting further evidence that Zomaril (iloperidone), their SDA for Scscott_jiminez-9/25/2000
56Marty, <b>Big</b> difference between having receptors targeted and tuck-9/11/2000
55I think he may have had some of the wholly owned NeoGene prospects in mind as weMarty-9/11/2000
54nigel, >"...more than 100 other drugs in our robust drug development pituck-9/11/2000
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):